Figure 4 | Scientific Reports

Figure 4

From: One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment

Figure 4

An 81-year-old woman who had received 3 intravitreal brolucizumab injections (IVBr) and an intravitreal aflibercept before the initial intravitreal faricimab (IVF) injection. (a) Optical coherence tomography (OCT) shows a relatively thin choroid and undilated choroidal vessels with infant intraretinal fluid and serous retinal pigment epithelium detachment (PED) at the initial IVF. (b) After the initial IVF. OCT shows PED increased. There was an increase in the PED height. Following a discussion with the patient, the decision was made to switch back to IVBr. (c) A year after the initial IVF. OCT shows low and wide serous PED. She received 6 IVBr after the initial IVF.

Back to article page